Cardiovascular Assessment in Patient Recovered From COVID-19 and Recovery of Autonomic Nervous System in Association With the Severity of the Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

67 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-18

Study Completion Date

2022-11-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the study is to assess autonomic nervous system and cardiovascular controll during orthostatic challenge in 90 patients recovered from COVID-19 and devided into three groups depend on severity of the morbidity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Autonomic Nervous System Affection Due to Post Covid Syndrome

NCT05502094

Long Covid19 Autonomic Dysfunction

COMPLETED

HERO System - Health Monitoring for the Detection of Vital Signs and Emotional States

NCT07248969

Cardiovascular

ACTIVE_NOT_RECRUITING

NC Testing in LC & POTS

NCT05914649

Postural Orthostatic Tachycardia Syndrome Post Acute Sequelae of SARS CoV 2 Infection

RECRUITING NA

Natural History Study of COVID-19 Using Digital Wearables

NCT04927442

COVID-19 Virus Disease

COMPLETED

COVID-19 Surveillance Based on Smart Wearable Device

NCT04459637

COVID-19

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COVID-severe

patient recovered from severe COVID desease

Group Type OTHER

Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity

Intervention Type OTHER

Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity during ten minutes in rest and ten minutes in orthostatic position

COVID-moderate

patient recovered from moderate COVID desease

Group Type OTHER

Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity

Intervention Type OTHER

Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity during ten minutes in rest and ten minutes in orthostatic position

COVID-mild

patient recovered from mild COVID desease

Group Type OTHER

Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity

Intervention Type OTHER

Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity during ten minutes in rest and ten minutes in orthostatic position

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity

Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity during ten minutes in rest and ten minutes in orthostatic position

Intervention Type OTHER